These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31863623)

  • 1. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
    Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
    J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia.
    Márton A; Veres KB; Erdődi F; Udvardy M; Illés Á; Rejtő L
    Pathol Oncol Res; 2024; 30():1611747. PubMed ID: 39035053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
    Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
    Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
    Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
    J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
    Zhu L; Wang X; Wang T; Zhu W; Zhou X
    Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
    Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
    J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
    Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
    Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turning off AKT: PHLPP as a drug target.
    Newton AC; Trotman LC
    Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
    Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
    Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
    Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
    Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.
    Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M
    Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells.
    Ghalali A; Ye ZW; Högberg J; Stenius U
    J Biol Chem; 2014 Apr; 289(17):11601-11616. PubMed ID: 24599953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.
    Song LB; Li J; Liao WT; Feng Y; Yu CP; Hu LJ; Kong QL; Xu LH; Zhang X; Liu WL; Li MZ; Zhang L; Kang TB; Fu LW; Huang WL; Xia YF; Tsao SW; Li M; Band V; Band H; Shi QH; Zeng YX; Zeng MS
    J Clin Invest; 2009 Dec; 119(12):3626-36. PubMed ID: 19884659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
    Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
    Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells.
    Ghalali A; Ye ZW; Högberg J; Stenius U
    Biomed Pharmacother; 2020 Jul; 127():110112. PubMed ID: 32294598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
    Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.